SOURCE-LINKED STUDY SUMMARY
Oxymetholone-Associated Cholestatic Drug-Induced Liver Injury With Profound Hyperbilirubinaemia: A Longitudinal Case Report.
Full paper summarizedQuality not appraised
- What was studied
- Full-paper case report followed suspected cholestatic liver injury after 29 days of self-administered oral oxymetholone 50 mg/day plus intramuscular testosterone enanthate 250 mg/week.
- Who / model studied
- One previously healthy 26-year-old male gym instructor presented with jaundice, dark urine, pale stools and severe itching.
- Studied dose & schedule
- The case report describes self-administered oral oxymetholone 50 mg/day with intramuscular testosterone enanthate 250 mg/week. Presentation was on day 29; both agents were withdrawn on day 30. Product identity was not chemically verified.
- What the study found
- Peak bilirubin was 24.6 mg/dL with cholestatic injury; synthetic and renal function remained preserved. After both agents stopped, bilirubin fell 91.5% by day 85.
- Limitations & context
- Single-case evidence cannot establish causation. Testosterone was coadministered, products were not chemically verified, and supportive treatment prevents attributing recovery to a specific intervention.
Read summary source ↗ · Prepared 9/23/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: full paper. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1155/crhe/2519455